Alpharma USPD, a subsidiary of Alpharma, has received approval from the United States Food and Drug Administration (FDA) to manufacture and market its betamethasone dipropionate and clotrimazole cream.

Alpharma's betamethasone dipropionate and clotrimazole cream is the generic equivalent of Lotrisone brand cream, marketed by Schering Plough. Lotrisone is indicated for the treatment of tinea pedis, tinea crusis, and tinea corpus. Brand sales of Lotrisone were approximately $30 million for the year-ended December 2001. Alpharma expects to launch this product in early 2003.

Lotrisone is a registered trademark of the Schering Corporation.